Mesenchymal stem cell‑derived exosomes: Regulators of progression and suppression in pancreatic cancer (Review)
Authors:
Open Access
- 4 November 2025
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 31 (1) , 1-12
Abstract
Pancreatic cancer is a malignant digestive tract tumor with a poor prognosis. It remains one of the most challenging malignancies due to difficulties in early diagnosis and the development of chemotherapy resistance in advanced stages. Mesenchymal stem cells (MSCs), a distinct type of non‑hematopoietic stem cells, play a crucial role in the tumor microenvironment owing to their unique tumor‑homing capacity and immunomodulatory properties, which are largely mediated by their derived exosomes (EXOs). EXOs derived from MSCs can regulate the growth, invasion and metastasis of pancreatic cancer through the activation of specific signaling pathways. Furthermore, they have emerged as promising drug delivery vehicles and have demonstrated potential in anti‑pancreatic cancer therapy. However, within the highly fibrotic tumor microenvironment of pancreatic cancer, the functions of MSC‑derived EXOs are complex and dualistic, exhibiting both tumor‑suppressive and tumor‑promoting effects. Understanding the precise roles of MSC‑derived EXOs in pancreatic cancer is essential for the development of effective therapeutic strategies. The present review systematically summarizes the dual regulatory mechanisms of MSC‑derived EXOs in pancreatic cancer, elucidates the key molecules and signaling pathways involved, and discusses their clinical potential as novel therapeutic targets or drug delivery systems.Keywords
This publication has 97 references indexed in Scilit:
- Exosome-mediated triple drug delivery enhances apoptosis in pancreatic cancer cellsApoptosis, 2025
- Exosomes: Methods for Isolation and Characterization in Biological Samples2024
- Genetically modified cancer vaccines: Current status and future prospectsMedicinal Research Reviews, 2022
- Pancreatic CancerJAMA, 2021
- Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancerCancer Medicine, 2019
- Comparison of immunomodulatory properties of exosomes derived from bone marrow mesenchymal stem cells and dental pulp stem cellsImmunologic Research, 2019
- Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem CellsStem Cells, 2014
- Proteomics, transcriptomics and lipidomics of exosomes and ectosomesProteomics, 2013
- Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma CellsStem Cells, 2010
- Studies on the Applicability of Artificial Neural Network (ANN) in Continuous Stirred UltrafiltrationChemical Engineering & Technology, 2002